Rouzbeh Razavi1, Amin Gharipour2, Mojgan Gharipour3. 1. Department of Management and Information Systems, Kent State University, Kent, OH, USA. 2. School of Information Technology, Griffith University, Gold Coast, Australia. 3. Isfahan Cardiovascular Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Abstract
OBJECTIVE: Depression is currently the second most significant contributor to non-fatal disease burdens globally. While it is treatable, depression remains undiagnosed in many cases. As mobile phones have now become an integral part of daily life, this study examines the possibility of screening for depressive symptoms continuously based on patients' mobile usage patterns. MATERIALS AND METHODS: 412 research participants reported a range of their mobile usage statistics. Beck Depression Inventory-2nd ed (BDI-II) was used to measure the severity of depression among participants. A wide array of machine learning classification algorithms was trained to detect participants with depression symptoms (ie, BDI-II score ≥ 14). The relative importance of individual variables was additionally quantified. RESULTS: Participants with depression were found to have fewer saved contacts on their devices, spend more time on their mobile devices to make and receive fewer and shorter calls, and send more text messages than participants without depression. The best model was a random forest classifier, which had an out-of-sample balanced accuracy of 0.768. The balanced accuracy increased to 0.811 when participants' age and gender were included. DISCUSSIONS/ CONCLUSION: The significant predictive power of mobile usage attributes implies that, by collecting mobile usage statistics, mental health mobile applications can continuously screen for depressive symptoms for initial diagnosis or for monitoring the progress of ongoing treatments. Moreover, the input variables used in this study were aggregated mobile usage metadata attributes, which has low privacy sensitivity making it more likely for patients to grant required application permissions.
OBJECTIVE:Depression is currently the second most significant contributor to non-fatal disease burdens globally. While it is treatable, depression remains undiagnosed in many cases. As mobile phones have now become an integral part of daily life, this study examines the possibility of screening for depressive symptoms continuously based on patients' mobile usage patterns. MATERIALS AND METHODS: 412 research participants reported a range of their mobile usage statistics. Beck Depression Inventory-2nd ed (BDI-II) was used to measure the severity of depression among participants. A wide array of machine learning classification algorithms was trained to detect participants with depression symptoms (ie, BDI-II score ≥ 14). The relative importance of individual variables was additionally quantified. RESULTS:Participants with depression were found to have fewer saved contacts on their devices, spend more time on their mobile devices to make and receive fewer and shorter calls, and send more text messages than participants without depression. The best model was a random forest classifier, which had an out-of-sample balanced accuracy of 0.768. The balanced accuracy increased to 0.811 when participants' age and gender were included. DISCUSSIONS/ CONCLUSION: The significant predictive power of mobile usage attributes implies that, by collecting mobile usage statistics, mental health mobile applications can continuously screen for depressive symptoms for initial diagnosis or for monitoring the progress of ongoing treatments. Moreover, the input variables used in this study were aggregated mobile usage metadata attributes, which has low privacy sensitivity making it more likely for patients to grant required application permissions.
Authors: Santosh Kumar; Gregory D Abowd; William T Abraham; Mustafa al'Absi; J Gayle Beck; Duen Horng Chau; Tyson Condie; David E Conroy; Emre Ertin; Deborah Estrin; Deepak Ganesan; Cho Lam; Benjamin Marlin; Clay B Marsh; Susan A Murphy; Inbal Nahum-Shani; Kevin Patrick; James M Rehg; Moushumi Sharmin; Vivek Shetty; Ida Sim; Bonnie Spring; Mani Srivastava; David W Wetter Journal: J Am Med Inform Assoc Date: 2015-07-03 Impact factor: 4.497
Authors: Sandy H Huang; Paea LePendu; Srinivasan V Iyer; Ming Tai-Seale; David Carrell; Nigam H Shah Journal: J Am Med Inform Assoc Date: 2014-07-02 Impact factor: 4.497
Authors: Aislinne Freeman; Stefanos Tyrovolas; Ai Koyanagi; Somnath Chatterji; Matilde Leonardi; Jose Luis Ayuso-Mateos; Beata Tobiasz-Adamczyk; Seppo Koskinen; Christine Rummel-Kluge; Josep Maria Haro Journal: BMC Public Health Date: 2016-10-19 Impact factor: 3.295
Authors: Valeria De Angel; Serena Lewis; Katie White; Carolin Oetzmann; Daniel Leightley; Emanuela Oprea; Grace Lavelle; Faith Matcham; Alice Pace; David C Mohr; Richard Dobson; Matthew Hotopf Journal: NPJ Digit Med Date: 2022-01-11
Authors: Jonah Meyerhoff; Tony Liu; Konrad P Kording; Lyle H Ungar; Susan M Kaiser; Chris J Karr; David C Mohr Journal: J Med Internet Res Date: 2021-09-03 Impact factor: 5.428